Research map: Analysis of the interventional effects of ambroxol hydrochloride and ontelukast sodium combined with azithromycin on immune function and C-reactive protein serum expression in children with severe Mycoplasma pneumoniae pneumonia

Back to the article

Papers in this map

  1. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies · Peter C. Austin · 2015 · 4545 citations · Cited by this paper
  2. Clinical features and nonoperative strategy for first-time infected urachal cysts in infants · 2026 · Related
  3. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement · Brian L. Graham · 2019 · 4329 citations · Cited by this paper
  4. Sex-stratified trends in hypoplastic left heart syndrome-related mortality among children and young adults in the United States, 1999–2024: a pre- and post-COVID-19 analysis · 2026 · Related
  5. Insight into the Pathogenic Mechanism of Mycoplasma pneumoniae · Jie Qiong Hu · 2022 · 173 citations · Cited by this paper
  6. Risk factors and a predictive model for delayed extubation in children undergoing primary repair of tetralogy of Fallot: a retrospective cohort study with rigorous methodological validation · 2026 · Related
  7. Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children · Yingshuo Wang · 2024 · 143 citations · Cited by this paper
  8. Correlation analysis of cyclosporine A trough concentration with hematological and biochemical parameters: a retrospective study in pediatric aplastic anemia · 2026 · Related
  9. Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide · Xiao Su · 2004 · 140 citations · Cited by this paper
  10. Artificial intelligence in pediatric arrhythmias: current landscape, unique challenges, and translational perspectives · 2026 · Related
  11. Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function · Annette J. Theron · 2014 · 116 citations · Cited by this paper
  12. KLF1 mutation-associated congenital dyserythropoietic anemia type IV: a case report and literature review · 2026 · Related
  13. Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010–2019 · Kuan-Lin Lee · 2020 · 115 citations · Cited by this paper
  14. Retrospective analysis of the clinical value of targeted nursing using a game-based model in children undergoing auricular reconstruction for congenital microtia · 2026 · Related
  15. Mycoplasma pneumoniae and Adenovirus Coinfection Cause Pediatric Severe Community-Acquired Pneumonia · Fei Li · 2022 · 70 citations · Cited by this paper
  16. Clinical application value of metagenomic next-generation sequencing in children with fever of unknown origin · 2026 · Related
  17. Serum cytokine profiling reveals different immune response patterns during general and severe Mycoplasma pneumoniae pneumonia · Zhikun Zhang · 2022 · 61 citations · Cited by this paper
  18. Multimodal quantitative characterization and mechanistic exploration of paraspinal muscle groups in adolescent idiopathic scoliosis · 2026 · Related
  19. Clinical Characteristics of Lung Consolidation with Mycoplasma pneumoniae Pneumonia and Risk Factors for Mycoplasma pneumoniae Necrotizing Pneumonia in Children · Xue Zhang · 2024 · 51 citations · Cited by this paper
  20. Precision minimally invasive strategy for Hirschsprung’s disease: from anatomical resection to whole-cycle functional management—a review · 2026 · Related
  21. A new dynamic nomogram for predicting the risk of severe Mycoplasma pneumoniae pneumonia in children · Xue Zhang · 2024 · 39 citations · Cited by this paper
  22. Clinical features of severe Mycoplasma pneumoniae pneumonia with pulmonary complications in childhood: A retrospective study · Xue qin Luo · 2023 · 34 citations · Cited by this paper
  23. [Expert consensus on laboratory diagnostics and clinical practice of Mycoplasma pneumoniae infection in children in China (2019)]. · 2020 · 33 citations · Cited by this paper
  24. Prediction Model for Severe Mycoplasma pneumoniae Pneumonia in Pediatric Patients by Admission Laboratory Indicators · Qing Hua Chang · 2022 · 27 citations · Cited by this paper
  25. Comparison of the efficacy of ambroxol hydrochloride and N‑acetylcysteine in the treatment of children with bronchopneumonia and their influence on prognosis · Hongbo Liu · 2020 · 21 citations · Cited by this paper
  26. Follow-up on the therapeutic effects of a budesonide, azithromycin, montelukast, and acetylcysteine (BAMA) regimen in children with post-infectious bronchiolitis obliterans · Tingting Weng · 2021 · 21 citations · Cited by this paper
  27. Therapeutic effect of budesonide, montelukast and azithromycin on post‑infectious bronchiolitis obliterans in children · Xia Chen · 2020 · 18 citations · Cited by this paper
  28. Unexpected increase of severe Mycoplasma pneumoniae pneumonia in adults in Southern Switzerland · Christian Garzoni · 2024 · 18 citations · Cited by this paper
  29. New-generation tetracyclines for severe macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a retrospective analysis · Xiaoxiao Song · 2024 · 17 citations · Cited by this paper
  30. ‘Unexpected increase of severe Mycoplasma pneumoniae pneumonia in adults in Southern Switzerland’ – Author’s reply · Christian Garzoni · 2024 · 11 citations · Cited by this paper
  31. Azithromycin sequential therapy plus inhaled terbutaline for Mycoplasma Pneumoniae pneumonia in children: a systematic review and meta-analysis · Yongcheng Sheng · 2024 · 11 citations · Cited by this paper
  32. Meta-analysis of the efficacy of budesonide and ambroxol hydrochloride inhalation in children with pneumonia and their effects on inflammatory response · Huanan Shen · 2023 · 10 citations · Cited by this paper
  33. Rural-urban differentials in child body mass index over time · Senahara Korsa Wake · 2023 · 7 citations · Cited by this paper
  34. Meta-analysis of combined azithromycin and inhaled budesonide treatment for Chinese pediatric patients with mycoplasma pneumonia · Jing Zhao · 2024 · 7 citations · Cited by this paper
  35. [Clinical phenotyping of severe Mycoplasma pneumoniae pneumonia in children]. · Haozhe Wang · 2024 · 7 citations · Cited by this paper
  36. Impact of montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19): protocol for an investigator-initiated open labeled randomized controlled pragmatic trial · Margarida Tavares · 2021 · 6 citations · Cited by this paper
  37. The efficacy of nebulized budesonide and ambroxol hydrochloride in treating pediatric community-acquired pneumonia and their impact on clinical characteristics and inflammatory markers · Xiaoqin Zhang · 2024 · 6 citations · Cited by this paper
  38. Effects of N-Acetylcysteine combined with Ambroxol Hydrochloride on clinical symptoms, CRP, and PCT in children with pneumonia · Aili Xue · 2024 · 6 citations · Cited by this paper
  39. Effect of azithromycin combined with ambroxol hydrochloride on immune response to mycoplasma pneumoniae pneumonia in children · Yunfen QIU · 2022 · 5 citations · Cited by this paper

Source: OpenAlex (CC0)